These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
316 related articles for article (PubMed ID: 7990847)
1. Characteristics of handwriting of patients with Huntington's disease. Phillips JG; Bradshaw JL; Chiu E; Bradshaw JA Mov Disord; 1994 Sep; 9(5):521-30. PubMed ID: 7990847 [TBL] [Abstract][Full Text] [Related]
2. Bradykinesia is not a "systematic" feature of adult-onset Huntington's disease; implications for basal ganglia pathophysiology. Fenney A; Jog MS; Duval C Brain Res; 2008 Feb; 1193():67-75. PubMed ID: 18177845 [TBL] [Abstract][Full Text] [Related]
4. Gait variability and basal ganglia disorders: stride-to-stride variations of gait cycle timing in Parkinson's disease and Huntington's disease. Hausdorff JM; Cudkowicz ME; Firtion R; Wei JY; Goldberger AL Mov Disord; 1998 May; 13(3):428-37. PubMed ID: 9613733 [TBL] [Abstract][Full Text] [Related]
5. Short-term variability in amplitude and motor topography of whole-body involuntary movements in Parkinson's disease dyskinesias and in Huntington's chorea. Fenney A; Jog MS; Duval C Clin Neurol Neurosurg; 2008 Feb; 110(2):160-7. PubMed ID: 18063471 [TBL] [Abstract][Full Text] [Related]
6. Beta-adrenergic receptor subtypes in the basal ganglia of patients with Huntington's chorea and Parkinson's disease. Waeber C; Rigo M; Chinaglia G; Probst A; Palacios JM Synapse; 1991 Aug; 8(4):270-80. PubMed ID: 1656540 [TBL] [Abstract][Full Text] [Related]
7. Inhibitory control during smooth pursuit in Parkinson's disease and Huntington's disease. Henderson T; Georgiou-Karistianis N; White O; Millist L; Williams DR; Churchyard A; Fielding J Mov Disord; 2011 Aug; 26(10):1893-9. PubMed ID: 21630355 [TBL] [Abstract][Full Text] [Related]
8. Impaired movement sequencing in patients with Huntington's disease: a kinematic analysis. Phillips JG; Chiu E; Bradshaw JL; Iansek R Neuropsychologia; 1995 Mar; 33(3):365-9. PubMed ID: 7792003 [TBL] [Abstract][Full Text] [Related]
9. Assessment of involuntary choreatic movements in Huntington's disease--toward objective and quantitative measures. Reilmann R; Bohlen S; Kirsten F; Ringelstein EB; Lange HW Mov Disord; 2011 Oct; 26(12):2267-73. PubMed ID: 21661053 [TBL] [Abstract][Full Text] [Related]
10. Effect of an attentional strategy on movement-related potentials recorded from subjects with Huntington's disease. Johnson KA; Cunnington R; Bradshaw JL; Chiu E; Iansek R Mov Disord; 2002 Sep; 17(5):998-1003. PubMed ID: 12360549 [TBL] [Abstract][Full Text] [Related]
11. Impairments of movement kinematics in patients with Huntington's disease: a comparison with and without a concurrent task. Georgiou N; Phillips JG; Bradshaw JL; Cunnington R; Chiu E Mov Disord; 1997 May; 12(3):386-96. PubMed ID: 9159734 [TBL] [Abstract][Full Text] [Related]
12. Computational analysis of open loop handwriting movements in Parkinson's disease: a rapid method to detect dopamimetic effects. Eichhorn TE; Gasser T; Mai N; Marquardt C; Arnold G; Schwarz J; Oertel WH Mov Disord; 1996 May; 11(3):289-97. PubMed ID: 8723147 [TBL] [Abstract][Full Text] [Related]
13. Quantitative measurement of handwriting in the assessment of drug-induced parkinsonism. Caligiuri MP; Teulings HL; Filoteo JV; Song D; Lohr JB Hum Mov Sci; 2006 Oct; 25(4-5):510-22. PubMed ID: 16647772 [TBL] [Abstract][Full Text] [Related]
14. Objective assessment of motor slowness in Huntington's disease: clinical correlates and 2-year follow-up. van Vugt JP; Piet KK; Vink LJ; Siesling S; Zwinderman AH; Middelkoop HA; Roos RA Mov Disord; 2004 Mar; 19(3):285-97. PubMed ID: 15022182 [TBL] [Abstract][Full Text] [Related]
15. Programming of single movements in Parkinson's disease: comparison with Huntington's disease. Jones DL; Phillips JG; Bradshaw JL; Iansek R; Bradshaw JA J Clin Exp Neuropsychol; 1992 Sep; 14(5):762-72. PubMed ID: 1474144 [TBL] [Abstract][Full Text] [Related]
16. Initiation and execution of movement sequences in those suffering from and at-risk of developing Huntington's disease. Bradshaw JL; Phillips JG; Dennis C; Mattingley JB; Andrewes D; Chiu E; Pierson JM; Bradshaw JA J Clin Exp Neuropsychol; 1992 Mar; 14(2):179-92. PubMed ID: 1533401 [TBL] [Abstract][Full Text] [Related]
17. Effects of deep brain stimulation and medication on bradykinesia and muscle activation in Parkinson's disease. Vaillancourt DE; Prodoehl J; Verhagen Metman L; Bakay RA; Corcos DM Brain; 2004 Mar; 127(Pt 3):491-504. PubMed ID: 14662520 [TBL] [Abstract][Full Text] [Related]
18. A computational model of Parkinsonian handwriting that highlights the role of the indirect pathway in the basal ganglia. Gangadhar G; Joseph D; Srinivasan AV; Subramanian D; Shivakeshavan RG; Shobana N; Chakravarthy VS Hum Mov Sci; 2009 Oct; 28(5):602-18. PubMed ID: 19720411 [TBL] [Abstract][Full Text] [Related]
20. Consistency of handwriting movements in dementia of the Alzheimer's type: a comparison with Huntington's and Parkinson's diseases. Slavin MJ; Phillips JG; Bradshaw JL; Hall KA; Presnell I J Int Neuropsychol Soc; 1999 Jan; 5(1):20-5. PubMed ID: 9989020 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]